Cabaletta Bio and Artisan Bio Announce Gene Editing Research and Collaboration Agreement to Develop Next-Generation CAAR T Cell Therapies


You May Also Like

Bellicum Pharmaceuticals Appoints Dr. William Grossman as Chief Medical Officer

HOUSTON, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing ...

BioSig Technologies’ CEO, Ken Londoner Interviewed by Medgadget

Minneapolis, MN, June 13, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device ...